Evaluation of the Effect of Febuxostat on Endothelial Dysfunction in Hemodialysis Patients.
Evaluation of the Effect of Febuxostat on Endothelial Dysfunction in Hemodialysis Patients.
The Purpose of this study is to determine if the Febuxostat has an effect on endothelial dysfunction on hemodialysis patients.
Aim of The Work:
1- Evaluation of the effect of febuxostat on endothelial dysfunction in hemodialysis patients, through detection of:
Primary endpoint:
• Reduction in Asymmetrical Dimethylarginine (ADMA)
Secondary endpoints:
Assessing the change in serum High sensitivity C-reactive protein (hsCRP)
Assessing the change in serum Uric acid - The criteria for inclusion:
The exclusion criteria:
After two months , the patient will be reassessed regarding:
A. ADMA serum level. B. Change in serum hsCRP. C. Change in serum Uric acid level.
Inclusion Criteria:
Exclusion Criteria: